Aurora Cannabis (ACB) Non-Current Assets (2018 - 2026)

Aurora Cannabis (ACB) posted quarterly Non-Current Assets of $148.5 million for Q1 2026, down 43.08% year-on-year from $260.9 million in Q1 2025, and down 43.08% on a QoQ basis from $260.9 million in Q1 2025.

Aurora Cannabis (ACB) Non-Current Assets (2018 - 2026) Analysis & Trends

Aurora Cannabis (ACB) has reported Non-Current Assets for 9 consecutive years, with $148.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Assets fell 43.08% year-over-year to $148.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $963.8 million (down 12.97% YoY) and the FY2026 annual result came in at $147.4 million, down 45.28% from the prior year.
  • Non-Current Assets declined to $148.5 million in Q1 2026 per ACB's latest filing, from $260.9 million in the prior quarter.
  • Over the last five years, Non-Current Assets for ACB reached as high as $330.2 million in Q1 2023 and fell as low as $148.5 million in Q1 2026.
  • A 5-year average of $269.7 million and a median of $277.2 million in 2024 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets tumbled 83.13% — and 2024, when it declined 7.39%.
  • Year by year, Non-Current Assets stood at $266.1 million in 2022, then advanced by 24.1% to $330.2 million in 2023, then dropped by 18.97% to $267.5 million in 2024, then declined by 2.49% to $260.9 million in 2025, then sank by 43.08% to $148.5 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $148.5 million, $260.9 million, and $267.5 million for Q1 2026, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn 148.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 148.49 Mn
Mar 31, 2025 260.88 Mn
Dec 31, 2024 267.55 Mn
Sep 30, 2024 286.86 Mn
Jun 30, 2024 292.13 Mn
Mar 31, 2024 305.80 Mn
Mar 31, 2023 330.20 Mn
Jun 30, 2022 266.08 Mn
Jun 30, 2021 1.58 Bn
Jun 30, 2020 1.70 Bn
Jun 30, 2019 3.62 Bn
Jun 30, 2018 1.29 Bn